GlobeNewswire Inc | Aug 4, 2021 04:05PM EDT

August 04, 2021

MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (Tactile Medical) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim 2021 MedTech Disruptors Summit, which is being held virtually from August 9th-10th. Management will participate in a fireside chat on Monday, August 9th at 3:00 p.m. Eastern Time.

AboutTactile Medical

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medicals Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Companys unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.



Investor Inquiries:Mike Piccinino, CFAManaging DirectorWestwickeinvestorrelations@tactilemedical.com